nobel biocare holding ag-reg
(NOBN:SIX Swiss Exchange)
Former Non-Executive Director, Chairman of Nomination & Compensation Committee and Member of Innovation & Technology Committee, Nobel Biocare Holding AG
|Age||Total Calculated Compensation||This person is connected to 12 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Ms. Daniela Bosshardt-Hengartner served as the Chief Financial Officer of Bellevue Asset Management. Ms. Bosshardt-Hengartner is an independent consultant in the area of financial analysis and business development for asset managers and companies. She was a Financial Analyst at the Bank am Bellevue from 1998 to 2002 and M2 Capital from 2003 to 2004. She served as management consultant in the Pharma, Medicinal Technology and Biotechnology sectors since 2004. She serves ...
Balz Zimmermann-Strasse 7Phone: 41 43 211 42 00
Kloten, Zurich 8302
Fax: 41 43 211 42 42
Board Members Memberships*
Director, Chairman of Remuneration Committee, Member of Scientific & Pharma Committee and Member of Swiss Healthcare Committee
Former Non-Executive Director, Chairman of Nomination & Compensation Committee and Member of Innovation & Technology Committee
Eidgenössische Technische Hochschule Zürich
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Stefano Pessina||Executive Vice Chairman and Acting Chief Executive Officer|
Walgreens Boots Alliance, Inc.
|George S. Barrett||Chairman, Chief Executive Officer and Chairman of Executive Committee|
Cardinal Health, Inc.
|John H. Hammergren||Chairman, Chief Executive Officer and President|
|Marc E. Owen||Chairman of the Management Board, Chief Operating Officer and Labour Relations Director|
|Liam M. FitzGerald||Chief Executive Officer, Executive Director and Member of Nomination Committee|
UDG Healthcare plc
|€978.0K||Compensation as of Fiscal Year --.|